Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1344061

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Budesonide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Royal College of Nursing on the use of the allergy drug Budesonide in the treatment of early covid-19 symptoms.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	28187
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Department has not had specific discussions with the Royal College of Nursing.</p><p>Inhaled budesonide was trialled as part of the PRINCIPLE trial platform in the United Kingdom as a treatment for COVID-19 in non-hospitalised patients who are 65 years old and over or 50 years old and over with an underlying health condition. On 12 April, interim analysis revealed that inhaled budesonide reduced the time to self-reported recovery by a median of three days. A complete analysis is currently underway to understand the full benefit. Clinical guidance has been issued for clinicians to consider prescribing inhaled budesonide on a case-by-case basis, but it is not currently recommended as the standard of care in the UK. The Department has briefed the Academy of Medical Royal Colleges on the recent results from the PRINCIPLE trial.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 14/07/2021 08:56:37 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1344062

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to control the transmission of the South African variant of covid-19 in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	28188
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Beta variant accounts for a relatively small amount of COVID-19 cases and is on the list of current variants of concern (VOC) monitored by Public Health England and forms part of the wider approach to dealing with VOCs. This includes the continuous tracking and identification of new strains and assessing their impact on the United Kingdom population.</p><p> </p><p>In response to VOCs, including the Beta variant, support measures have been made available to local authorities, including surge testing, enhanced contact tracing, faster standard tracing for all cases in the area as well as direct reporting into a national incident management structure to ensure a consistent and timely response.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 14/07/2021 09:47:10 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1344063

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have acne in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	28189
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>I refer the hon. Member to the answer I gave on 7 July 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-07-01/25819" target="_blank">25819</a>.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/07/2021 10:31:19 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1344064

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of pancreatic cancer patients were prescribed pancreatic enzyme replacement therapy in England in (a) 2015, (b) 2016, (c) 2017, (d) 2018 and (e) 2019.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28227
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The information requested is not held centrally. While the NHS Business Services Authority holds prescription data relating to drugs dispensed within a community setting, no data is collected on the clinical condition of the patient.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 14/07/2021 09:42:54 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1344065

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the prescription rates of pancreatic enzyme replacement therapy for inoperable pancreatic cancer patients in England who are not treated in specialist centres.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28228
answer	answer is ministerial correction date of answer 08/07/2021 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Slough (Mr Tanmanjeet Singh Dhesi MP) on 10 June 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-06-07/11722" target="_blank">11722</a>.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 28229 question first answered 08/07/2021 16:50:42 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1344066

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure pancreatic cancer patients are considered for pancreatic enzyme replacement therapy at the point of diagnosis in England.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28229
answer	answer is ministerial correction date of answer 08/07/2021 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Slough (Mr Tanmanjeet Singh Dhesi MP) on 10 June 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-06-07/11722" target="_blank">11722</a>.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 28228 question first answered 08/07/2021 16:50:42 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1344067

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Steroid Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with stakeholders on the recognition of topical steroid withdrawal as an official condition by the NHS.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28230
answer	answer is ministerial correction date of answer 28/07/2021 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a review of topical steroid withdrawal. The review is discussing alterations to labelling, guidance and communications with health care professionals. We have consulted on these topics with healthcare experts in the field including those in the National Health Service, patient representatives and other stakeholders. We are considering updates to the product information and further communications to health care professionals and the MHRA expects to issue more information on this in the next few months.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 28231 28232 question first answered 28/07/2021 12:13:02 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4433 label Biography information for Thangam Debbonaire

1344068

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Steroid Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on guidance for GPs and patients on the correct use and dosage of topical steroids.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28231
answer	answer is ministerial correction date of answer 28/07/2021 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a review of topical steroid withdrawal. The review is discussing alterations to labelling, guidance and communications with health care professionals. We have consulted on these topics with healthcare experts in the field including those in the National Health Service, patient representatives and other stakeholders. We are considering updates to the product information and further communications to health care professionals and the MHRA expects to issue more information on this in the next few months.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 28230 28232 question first answered 28/07/2021 12:13:02 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4433 label Biography information for Thangam Debbonaire

1344069

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Steroid Drugs: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to modify the labelling of topical steroid medications to include clear warnings against over-use.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28232
answer	answer is ministerial correction date of answer 28/07/2021 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a review of topical steroid withdrawal. The review is discussing alterations to labelling, guidance and communications with health care professionals. We have consulted on these topics with healthcare experts in the field including those in the National Health Service, patient representatives and other stakeholders. We are considering updates to the product information and further communications to health care professionals and the MHRA expects to issue more information on this in the next few months.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 28230 28231 question first answered 28/07/2021 12:13:02 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4433 label Biography information for Thangam Debbonaire

1344074

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Software
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to improve the speed and consistency of information and payments to GP practices using the new Primary Care Support England (PCSE) payment software.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	28233
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>Primary Care Support England (PCSE), a service operated by Capita on behalf of NHS England and NHS Improvement, implemented a new general practitioner payment and pensions system, PCSE Online, on 1 June 2021. Since June the new payments system has successfully processed over 187,000 payment lines, totalling £970 million. Payments to general practice are made on a set schedule in line with contractual deadlines and NHS England and NHS Improvement has advised that all expected payments have been made, including any corrections that were made in-month to ensure that all contractual deadlines were met. PCSE has advised that it continues to work with stakeholders to monitor the new system and address any issues.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/07/2021 16:32:25 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire